BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8262840)

  • 1. Erythropoietin increases hemoglobin in cancer patients during radiation therapy.
    Lavey RS; Dempsey WH
    Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1147-52. PubMed ID: 8262840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin increases hemoglobin during radiation therapy for cervical cancer.
    Dusenbery KE; McGuire WA; Holt PJ; Carson LF; Fowler JM; Twiggs LB; Potish RA
    Int J Radiat Oncol Biol Phys; 1994 Jul; 29(5):1079-84. PubMed ID: 8083076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx.
    Glaser CM; Millesi W; Kornek GV; Lang S; Schüll B; Watzinger F; Selzer E; Lavey RS
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):705-15. PubMed ID: 11395239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of subcutaneous recombinant human erythropoietin in cancer patients receiving radiotherapy: final report of a randomized, open-labelled, phase II trial.
    Sweeney PJ; Nicolae D; Ignacio L; Chen L; Roach M; Wara W; Marcus KC; Vijayakumar S
    Br J Cancer; 1998 Jun; 77(11):1996-2002. PubMed ID: 9667681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human erythropoietin in the anemia of prematurity: results of a placebo-controlled pilot study.
    Shannon KM; Mentzer WC; Abels RI; Freeman P; Newton N; Thompson D; Sniderman S; Ballard R; Phibbs RH
    J Pediatr; 1991 Jun; 118(6):949-55. PubMed ID: 2040933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Prevalence of Iron Deficiency Despite Standardized High-Dose Iron Supplementation During Recombinant Erythropoietin Therapy in Extremely Low Gestational Age Newborns.
    Siddappa AM; Olson RM; Spector M; Northrop E; Zamora T; Brearley AM; Georgieff MK; Rao R
    J Pediatr; 2020 Jul; 222():98-105.e3. PubMed ID: 32418819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of subcutaneous r-HuEPO in cancer patients receiving chemotherapy with anemia: a preliminary report.
    Chiou TJ; Chim YS; Wei CH; Hsieh RK; Chen PM
    Zhonghua Yi Xue Za Zhi (Taipei); 1997 Nov; 60(5):229-35. PubMed ID: 9509677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Multicenter study of darbepoetin alfa in the treatment of anemia secondary to chronic renal insufficiency on dialysis].
    Martínez Castelao A; Reyes A; Valdés F; Otero A; López de Novales E; Pallardó L; Tabernero JM; Hernández Jaras J; Lladós F
    Nefrologia; 2003; 23(2):114-24. PubMed ID: 12778875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results.
    Phair JP; Abels RI; McNeill MV; Sullivan DJ
    Arch Intern Med; 1993 Dec; 153(23):2669-75. PubMed ID: 8250662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of subcutaneous recombinant human erythropoietin (r-HuEPO) on anemia in cancer patients receiving platinum-based chemotherapy.
    Malik IA; Khan ZK; Hakimali A; Sabih M; Rehman G
    J Pak Med Assoc; 1998 May; 48(5):127-31. PubMed ID: 9813972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerance of treatment with recombinant-human erythropoietin in chronic renal failure (pre-dialysis) patients.
    Frenken LA; Verberckmoes R; Michielsen P; Koene RA
    Nephrol Dial Transplant; 1989; 4(9):782-6. PubMed ID: 2516609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of erythropoiesis by recombinant human erythropoietin in low birth weight infants: a pilot study.
    Shannon KM; Mentzer WC; Abels RI; Wertz M; Thayer-Moriyama J; Li WY; Thompson D; Decelle S; Phibbs RH
    J Pediatr; 1992 Apr; 120(4 Pt 1):586-92. PubMed ID: 1372652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human erythropoietin for the treatment of anemia in children with solid malignant tumors.
    León P; Jiménez M; Barona P; Sierrasesúmaga L
    Med Pediatr Oncol; 1998 Feb; 30(2):110-6. PubMed ID: 9403020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human erythropoietin in the treatment of anemia associated with human immunodeficiency virus (HIV) infection and zidovudine therapy. Overview of four clinical trials.
    Henry DH; Beall GN; Benson CA; Carey J; Cone LA; Eron LJ; Fiala M; Fischl MA; Gabin SJ; Gottlieb MS
    Ann Intern Med; 1992 Nov; 117(9):739-48. PubMed ID: 1416576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The treatment of anemia of hemodialysis patients using recombinant human erythropoietin: comparison between intravenous and subcutaneous administration].
    Zehnder C; Blumberg A
    Schweiz Med Wochenschr; 1990 Feb; 120(7):217-20. PubMed ID: 2309110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and safety of recombinant human erythropoietin (r-HuEPO) in the treatment of anemia of chronic renal failure in non dialysis patients. European Multicentre Study Group.
    Kulzer P; Schaefer RM; Krahn R; Schaefer L; Heidland A
    Int J Artif Organs; 1994 Apr; 17(4):195-202. PubMed ID: 8070941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind randomized control trial of the effect of recombinant human erythropoietin on chemotherapy-induced anemia in patients with non-small cell lung cancer.
    Kunikane H; Watanabe K; Fukuoka M; Saijo N; Furuse K; Ikegami H; Ariyoshi Y; Kishimoto S
    Int J Clin Oncol; 2001 Dec; 6(6):296-301. PubMed ID: 11828949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of subcutaneous recombinant human erythropoietin in cancer patients receiving radiotherapy: preliminary results of a randomized, open-labeled, phase II trial.
    Vijayakumar S; Roach M; Wara W; Chan SK; Ewing C; Rubin S; Sutton H; Halpern H; Awan A; Houghton A
    Int J Radiat Oncol Biol Phys; 1993 Jul; 26(4):721-9. PubMed ID: 8331011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proposed therapeutic algorithm for the treatment of anemia of chronic renal failure in pre-dialysis patients with low dose once weekly subcutaneous r-HuEPO. Multicenter Study Group, Israel.
    Yagil Y
    Isr J Med Sci; 1997 Jan; 33(1):36-44. PubMed ID: 9203516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The utility of a growth factor: r-HuEPO as a treatment for preoperative autologous blood donation in gynecological tumor surgery.
    Gargano G; Polignano G; De Lena M; Brandi M; Lorusso V; Fanizza G
    Int J Oncol; 1999 Jan; 14(1):157-60. PubMed ID: 9863023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.